Stay updated on Biosimilar Ustekinumab vs Stelara Clinical Trial
Sign up to get notified when there's something new on the Biosimilar Ustekinumab vs Stelara Clinical Trial page.

Latest updates to the Biosimilar Ustekinumab vs Stelara Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedFooter updates include the addition of 'Revision: v3.3.3' and removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'; these changes are cosmetic and do not affect the study content, eligibility criteria, endpoints, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing v3.3.1. This change does not affect the study details or the information displayed on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedPublications are described as automatically filled from PubMed. The page revision is updated to v3.3.1, replacing the previous v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedNotice about government funding lapse was removed; the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedOnly cosmetic UI/layout adjustments were observed (e.g., header alignment and spacing) with no changes to core trial details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check99 days agoChange DetectedUpgrade notice added: government funding lapse alert and current status of NIH Clinical Center with update links, plus version bumped to v3.2.0; old version reference v3.1.0 removed.SummaryDifference4%

Stay in the know with updates to Biosimilar Ustekinumab vs Stelara Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biosimilar Ustekinumab vs Stelara Clinical Trial page.